SKI Market

Indian Indices

Sensex

80,238.85 -1,048.34
( -1.29%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

57,982.65 -867.62
(-1.47%)

Nikkei 225

10,782.87 -127.68
(-1.17%)

Forex

USD-INR

90.93 0.01
(0.01%)

EUR-INR

107.33 0.10
(0.10%)

GBP-INR

122.97 -0.01
(-0.01%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Parenteral Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524689

INE904D01019

-300.6045095

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PDPL

10.11

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)	Mar 2017 ( Cr)	Mar 2016 ( Cr)
Sales Turnover	12.17	31.87	33.23	32.97	52.65	152.27
Excise Duty	0.00	0.00	0.02	0.02	0.44	3.49
Net Sales	12.17	31.87	33.21	32.95	52.21	148.78
Other Income	0.06	0.25	0.24	1.34	2.53	1.91
Stock Adjustments	0.62	-1.14	1.11	-1.06	-3.09	-23.56
Total Income	12.85	30.98	34.56	33.23	51.65	127.13
EXPENDITURE :
Raw Materials	6.28	5.18	7.57	5.70	22.94	99.63
Power & Fuel Cost	0.71	9.57	10.87	8.47	8.45	0.00
Employee Cost	14.51	19.21	19.94	16.70	15.11	11.80
Other Manufacturing Expenses	0.94	6.80	7.09	6.13	7.78	13.77
Selling & Administrative Expenses	1.76	3.60	4.70	7.93	12.55	23.40
Miscellaneous Expenses	0.36	1.06	0.61	2.81	16.95	24.56
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	24.56	45.42	50.78	47.73	83.78	173.16
Operating Profit	-11.70	-14.43	-16.23	-14.50	-32.12	-46.03
Interest	125.44	109.96	96.05	86.34	73.94	58.01
Gross Profit	-137.14	-124.39	-112.28	-100.84	-106.06	-104.04
Depreciation	17.33	17.35	69.12	18.57	19.10	17.06
Profit Before Tax	-154.47	-141.74	-181.40	-119.41	-125.16	-121.10
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-32.76	-27.66	-33.49	-23.31	-11.08	-12.61
Reported Net Profit	-121.71	-114.07	-147.90	-96.09	-114.09	-108.49
Extraordinary Items	0.00	0.00	0.00	0.00	-0.10	-0.54
Adjusted Net Profit	-121.71	-114.07	-147.90	-96.09	-113.99	-107.95
Adjustment below Net Profit	0.14	-0.31	-0.25	-0.02	-0.30	0.00
P & L Balance brought forward	-913.41	-799.02	-650.87	-554.75	-440.36	-187.64
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-1034.97	-913.41	-799.02	-650.87	-554.75	-296.13
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-40.82	-38.26	0.00	0.00	0.00	0.00
Earnings Per Share(Adj)-Unit Curr	-40.82	-38.26	0.00	0.00	0.00	0.00
Book Value-Unit Curr	-264.89	-224.12	-185.75	-136.07	-103.83	4.36
Book Value(Adj)-Unit Curr	-264.89	-224.12	-185.75	-136.07	-103.83	4.36

80,238.85 -1,048.34 ( -1.29%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

57,982.65 -867.62 (-1.47%)

10,782.87 -127.68 (-1.17%)

90.93 0.01 (0.01%)

107.33 0.10 (0.10%)

122.97 -0.01 (-0.01%)

0.58 0.00 (0.12%)